244 related articles for article (PubMed ID: 36466914)
41. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M
Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
[No Abstract] [Full Text] [Related]
42. Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight.
López-Bermejo A; Fernández-Real JM; Garrido E; Rovira R; Brichs R; Genaró P; Bach C; Cabrero D; Kihara S; Funahashi T; Vendrell J; Ricart W
Clin Endocrinol (Oxf); 2004 Nov; 61(5):544-52. PubMed ID: 15521955
[TBL] [Abstract][Full Text] [Related]
43. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
[TBL] [Abstract][Full Text] [Related]
44. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
45. Possible association of tumor necrosis factor receptor 2 gene polymorphism with severe hypertension using the extreme discordant phenotype design.
Eguchi T; Maruyama T; Ohno Y; Morii T; Hirao K; Hirose H; Kawabe H; Saito I; Hayashi M; Saruta T
Hypertens Res; 2009 Sep; 32(9):775-9. PubMed ID: 19557004
[TBL] [Abstract][Full Text] [Related]
46. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
47. Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker.
Zhang YW; Chen QQ; Cao J; Xu LQ; Tang X; Wang J; Zhang J; Dong LX
Thorac Cancer; 2019 Mar; 10(3):437-444. PubMed ID: 30628200
[TBL] [Abstract][Full Text] [Related]
48. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis.
Bessa TF; Cordeiro CA; Gonçalves RM; Young LH; Campos WR; Oréfice F; Teixeira AL
Braz J Infect Dis; 2012; 16(6):540-4. PubMed ID: 23141990
[TBL] [Abstract][Full Text] [Related]
49. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
50. Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia.
Kudo N; Yamamori H; Ishima T; Nemoto K; Yasuda Y; Fujimoto M; Azechi H; Niitsu T; Numata S; Ikeda M; Iyo M; Ohmori T; Fukunaga M; Watanabe Y; Hashimoto K; Hashimoto R
Int J Neuropsychopharmacol; 2018 Jul; 21(7):631-639. PubMed ID: 29529289
[TBL] [Abstract][Full Text] [Related]
51. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
52. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
[TBL] [Abstract][Full Text] [Related]
53. Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.
Zhou Q; Li W; Leng B; Zheng W; He Z; Zuo M; Chen A
PLoS One; 2016; 11(6):e0155495. PubMed ID: 27253331
[TBL] [Abstract][Full Text] [Related]
54. Circulating C-peptide level is a predictive factor for colorectal neoplasia: evidence from the meta-analysis of prospective studies.
Chen L; Li L; Wang Y; Li P; Luo L; Yang B; Wang H; Chen M
Cancer Causes Control; 2013 Oct; 24(10):1837-47. PubMed ID: 23846284
[TBL] [Abstract][Full Text] [Related]
55. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
56. An alternatively spliced soluble TNF-alpha receptor is associated with metabolic disorders: a replication study.
Fernández-Real JM; Botas-Cervero P; Lainez B; Ricart W; Delgado E
Clin Immunol; 2006 Nov; 121(2):236-41. PubMed ID: 16979382
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor receptor 2 may promote the proliferation and drug resistance of Kapras299 and L428 lymphoma cells via the AKT and WNT/β-catenin signaling pathways.
Liang Y; Wang Y; Xiao M; Hao Y; Zhang Y; Li S
Oncol Lett; 2018 Jun; 15(6):8847-8852. PubMed ID: 29928327
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
[TBL] [Abstract][Full Text] [Related]
59. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis.
Larsson SC; Wolk A
Int J Cancer; 2007 Oct; 121(7):1564-70. PubMed ID: 17443495
[TBL] [Abstract][Full Text] [Related]
60. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
